Recent 13F filings as of December 2025 show that 92 institutional investors hold a position in Galectin Therapeutics Inc (NASDAQ:GALT).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,288,848 | 40,881 | 1.82% | $9,521,608.00 |
| OSAIC HOLDINGS, INC. | 31 Dec, 2025 | 1,090,590 | -134,134 | -10.95% | $4,536,850.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 796,558 | -1,111 | -0.14% | $3,313,681.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 602,134 | 47,873 | 8.64% | $2,504,877.00 |
| Wealthspire Advisors, LLC | 31 Dec, 2025 | 601,973 | 122,455 | 25.54% | $2,504,208.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 598,074 | -34,993 | -5.53% | $2,489,234.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 379,639 | 364,963 | 2,486.80% | $1,579,299.00 |
| COMMONWEALTH EQUITY SERVICES, LLC | 31 Dec, 2025 | 334,096 | 39,195 | 13.29% | $1,389,840.00 |
| LPL Financial LLC | 31 Dec, 2025 | 325,256 | -35,012 | -9.72% | $1,353,065.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 307,229 | 285,215 | 1,295.61% | $1,278,073.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 286,919 | -159,659 | -35.75% | $1,193,583.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 279,288 | 50,953 | 22.32% | $1,161,837.00 |
| Geneos Wealth Management Inc. | 31 Dec, 2025 | 243,327 | -116,848 | -32.44% | $1,012,240.00 |
| STATE STREET CORP | 31 Dec, 2025 | 242,232 | 11,892 | 5.16% | $1,007,685.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 235,508 | 125,086 | 113.28% | $979,713.00 |
| Sovran Advisors, LLC | 31 Dec, 2025 | 225,874 | 68,469 | 43.50% | $711,503.00 |
| Vivaldi Capital Management LP | 31 Dec, 2025 | 204,070 | -51,682 | -20.21% | $848,931.00 |
| RETIREMENT GUYS FORMULA LLC | 31 Dec, 2025 | 184,562 | 18,569 | 11.19% | $767,778.00 |
| 683 Capital Management, LLC | 31 Dec, 2025 | 162,484 | 162,484 | 0.00% | $675,933.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 142,220 | 142,220 | 0.00% | $591,635.00 |